This inventor holds 1 USPTO granted patent. Top assignee: Zeneca Limited. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Douglas Stephen Paterson: Innovator in Tumor-Associated Antibodies
Introduction
Douglas Stephen Paterson is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target tumor-associated antigens. His work has implications for cancer research and treatment.
Latest Patents
Paterson holds a patent for "Antibodies recognizing tumor associated antigen CA 55.1." This patent describes antibodies that recognize a tumor-related antigen designated CA55.1, including hybridoma 55.1, which is deposited as ECACC deposit no. 93081901. The complementarity determining regions of these antibodies have specific sequences that are crucial for their function.
Career Highlights
Throughout his career, Douglas Paterson has been associated with Zeneca Limited, a prominent company in the pharmaceutical and biotechnology sectors. His work at Zeneca has allowed him to focus on innovative solutions in cancer treatment.
Collaborations
Paterson has collaborated with esteemed colleagues, including Clive Graham Copley and Susan Margaret Hall. These partnerships have enhanced the research and development of his patented technologies.
Conclusion
Douglas Stephen Paterson's contributions to the field of biotechnology, particularly in the development of tumor-associated antibodies, highlight his role as an innovator. His work continues to influence cancer research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile